SYNGENE INTERNATIONAL
Quarterly Results Analysis [Dec2023]
SYNGENE INTERNATIONAL Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹854 Cr | ₹910 Cr | ₹808 Cr | ₹994 Cr | ₹786 Cr | ₹768 Cr | ₹645 Cr | ₹758 Cr |
Expenses | ₹622 Cr | ₹656 Cr | ₹596 Cr | ₹680 Cr | ₹555 Cr | ₹552 Cr | ₹472 Cr | ₹517 Cr |
Operating Income | ₹232 Cr | ₹254 Cr | ₹212 Cr | ₹314 Cr | ₹231 Cr | ₹217 Cr | ₹173 Cr | ₹241 Cr |
Other Income | ₹29 Cr | ₹22 Cr | ₹24 Cr | ₹23 Cr | ₹17 Cr | ₹15 Cr | ₹16 Cr | ₹24 Cr |
Interest | ₹11 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹12 Cr | ₹9 Cr | ₹6 Cr |
Depreciation | ₹108 Cr | ₹105 Cr | ₹102 Cr | ₹96 Cr | ₹95 Cr | ₹90 Cr | ₹86 Cr | ₹80 Cr |
Profit Before Tax | ₹138 Cr | ₹151 Cr | ₹123 Cr | ₹231 Cr | ₹140 Cr | ₹130 Cr | ₹93 Cr | ₹179 Cr |
Profit After Tax | ₹112 Cr | ₹117 Cr | ₹93 Cr | ₹179 Cr | ₹110 Cr | ₹102 Cr | ₹74 Cr | ₹148 Cr |
EPS | ₹2.77 | ₹2.90 | ₹2.32 | ₹4.45 | ₹2.73 | ₹2.54 | ₹1.84 | ₹3.69 |
Industry Peers & Returns | 1W | 1M | 1Y |
SYNGENE INTERNATIONAL | -1.6% | -10.8% | 16.2% |
BLS INTERNATIONAL SERVICES | 2.7% | -7% | 126.5% |
LATENT VIEW ANALYTICS | -7.4% | -14.2% | 35.7% |
QUESS CORP | 0.8% | -0.4% | 39.6% |
DELTA CORP | -4.2% | -11.9% | -34.5% |
SUN PHARMA ADVANCED RESEARCH COMPANY | -3.6% | 0.7% | 92.3% |
SECURITY AND INTELLIGENCE SERVICES INDIA | -1.4% | 1% | 27.6% |
JUST DIAL | -6.6% | -8.5% | 33.5% |
TEAMLEASE SERVICES | -3.1% | -11.1% | 16.4% |
SYNGENE INTERNATIONAL Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -6.22 % |
Y-o-Y | 8.60 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹854 Cr | -6.22 | |
Sep2023 | ₹910 Cr | 12.62 | |
Jun2023 | ₹808 Cr | -18.73 | |
Mar2023 | ₹994 Cr | 26.53 | |
Dec2022 | ₹786 Cr | 2.32 | |
Sep2022 | ₹768 Cr | 19.18 | |
Jun2022 | ₹645 Cr | -14.98 | |
Mar2022 | ₹758 Cr | - |
SYNGENE INTERNATIONAL Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -8.89 % |
Y-o-Y | 0.22 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹232 Cr | -8.89 | |
Sep2023 | ₹254 Cr | 19.92 | |
Jun2023 | ₹212 Cr | -32.54 | |
Mar2023 | ₹314 Cr | 35.97 | |
Dec2022 | ₹231 Cr | 6.70 | |
Sep2022 | ₹217 Cr | 25.29 | |
Jun2022 | ₹173 Cr | -28.36 | |
Mar2022 | ₹241 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -2.87 % |
Y-o-Y | -7.72 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 27.12% | -2.87 | |
Sep2023 | 27.92% | 6.48 | |
Jun2023 | 26.22% | -17.00 | |
Mar2023 | 31.59% | 7.49 | |
Dec2022 | 29.39% | 4.26 | |
Sep2022 | 28.19% | 5.15 | |
Jun2022 | 26.81% | -15.74 | |
Mar2022 | 31.82% | - |
SYNGENE INTERNATIONAL Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -4.29 % |
Y-o-Y | 1.64 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹112 Cr | -4.29 | |
Sep2023 | ₹117 Cr | 24.73 | |
Jun2023 | ₹93 Cr | -47.73 | |
Mar2023 | ₹179 Cr | 62.90 | |
Dec2022 | ₹110 Cr | 7.55 | |
Sep2022 | ₹102 Cr | 38.02 | |
Jun2022 | ₹74 Cr | -50.00 | |
Mar2022 | ₹148 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.03 % |
Y-o-Y | -6.45 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 13.06 % | 2.03 | |
Sep2023 | 12.8 % | 10.73 | |
Jun2023 | 11.56 % | -35.67 | |
Mar2023 | 17.97 % | 28.72 | |
Dec2022 | 13.96 % | 5.12 | |
Sep2022 | 13.28 % | 15.78 | |
Jun2022 | 11.47 % | -41.18 | |
Mar2022 | 19.5 % | - |
SYNGENE INTERNATIONAL Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -4.48 % |
Y-o-Y | 1.47 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹2.77 | -4.48 | |
Sep2023 | ₹2.9 | 25.00 | |
Jun2023 | ₹2.32 | -47.87 | |
Mar2023 | ₹4.45 | 63.00 | |
Dec2022 | ₹2.73 | 7.48 | |
Sep2022 | ₹2.54 | 38.04 | |
Jun2022 | ₹1.84 | -50.14 | |
Mar2022 | ₹3.69 | - |
You may also like the below Video Courses
SYNGENE INTERNATIONAL LTD vs BLS INTERNATIONAL SERVICES LTD vs LATENT VIEW ANALYTICS LTD
QUESS CORP LTD vs DELTA CORP LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD